Correction to: Geraniin Inhibits LPS-Induced THP-1 Macrophages Switching to M1 Phenotype via SOCS1/NF-κB Pathway (Inflammation, (2016), 39, 4, (1421-1433), 10.1007/s10753-016-0374-7);Geraniin Inhibits LPS-Induced THP-1 Macrophages Switching to M1 Phenotype via SOCS1/NF-κB Pathway

Inflammation

Volumn 39, Issue 4, 2016, Pages 1421-1433

  Liu, Xinxin ^a   Li, Ji ^a   Peng, Xiaohong ^b   Lv, Bo ^a   Wang, Peng ^c   Zhao, Xiaoming ^a,d   Yu, Bo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Lumber Industry General Hospital   (China)

^c NORTHEAST FORESTRY UNIVERSITY   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

geraniin; inflammation; macrophage polarization; NF B; SOCS1

Indexed keywords

ANTIINFLAMMATORY AGENT; GERANIIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; GLUCOSIDE; SOCS1 PROTEIN, HUMAN; TANNIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; IMMUNOREGULATION; MACROPHAGE; MACROPHAGE SWITCHING; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THP 1 MACROPHAGE; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; GLUCOSIDES; HUMANS; HYDROLYZABLE TANNINS; LIPOPOLYSACCHARIDES; MACROPHAGES; NF-KAPPA B; PHENOTYPE; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING 1 PROTEIN; TRANSCRIPTION FACTOR RELA;

EID: 84979022658     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-020-01351-5     Document Type: Erratum

References (42)

1. Mozaffarian, D., E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, S. de Ferranti, J.P. Despres, H.J. Fullerton, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, S. Liu, R.H. Mackey, D.B. Matchar, D.K. McGuire, E.R. Mohler 3rd, C.S. Moy, P. Muntner, M.E. Mussolino, K. Nasir, R.W. Neumar, G. Nichol, L. Palaniappan, D.K. Pandey, M.J. Reeves, C.J. Rodriguez, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, J.Z. Willey, D. Woo, R.W. Yeh, and M.B. Turner. 2015. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131(4): e29–e322.
2. Hansson, G.K., and A. Hermansson. 2011. The immune system in atherosclerosis. Nature Immunology 12(3): 204–212.
3. Li, X., M.C. Kramer, C.M. van der Loos, K.T. Koch, O.J. de Boer, J.P. Henriques, J. Baan Jr., M.M. Vis, J.J. Piek, J.G. Tijssen, R.J. de Winter, and A.C. van der Wal. 2011. A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction. Atherosclerosis 218(1): 83–89.
4. Rigamonti, E., and P. Zordan. 2014. Macrophage plasticity in skeletal muscle repair. 2014:560629.
5. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nature Reviews Immunology 11(11): 750–761.
6. Murray, P.J., and T.A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 11(11): 723–737.
7. Colin, S., G. Chinetti-Gbaguidi, and B. Staels. 2014. Macrophage phenotypes in atherosclerosis. Immunology Reviews 262(1): 153–166.
8. Agrawal, M. 2015. Natural polyphenols based new therapeutic avenues for advanced biomedical applications. Drug Metabolism Reviews 47(4): 420–430.
9. Joven, J., A. Rull, E. Rodriguez-Gallego, J. Camps, M. Riera-Borrull, A. Hernandez-Aguilera, V. Martin-Paredero, A. Segura-Carretero, V. Micol, C. Alonso-Villaverde, and J.A. Menendez. 2013. Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism. Food and Chemical Toxicology 51: 267–279.
10. Gonzalez, R., I. Ballester, R. Lopez-Posadas, M.D. Suarez, A. Zarzuelo, O. Martinez-Augustin, and F. Sanchez de Medina. 2011. Effects of flavonoids and other polyphenols on inflammation. Critical Reviews in Food Science and Nutrition 51(4): 331–362.
11. Impellizzeri, D., E. Talero, R. Siracusa, A. Alcaide, M. Cordaro, J. Maria Zubelia, G. Bruschetta, R. Crupi, E. Esposito, S. Cuzzocrea, and V. Motilva. 2015. Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice. British Journal of Nutrition 114(6): 853–865.
12. Lee, W., S.K. Ku, and J.S. Bae. 2015. Anti-inflammatory effects of Baicalin, Baicalein, and Wogonin in vitro and in vivo. Inflammation 38(1): 110–125.
13. Perera, A., S.H. Ton, and U.D. Palanisamy. 2015. Perspectives on Geraniin, a multifunctional natural bioactive compound. Trends in Food Science & Technology 44(2): 243–257.
14. Ko, H. 2015. Geraniin inhibits TGF-β1-induced epithelial–mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance. Bioorganic & Medicinal Chemistry Letters 25(17): 3529–3534.
15. Lu, Y., B. He, X. Zhang, R. Yang, S. Li, B. Song, Y. Zhang, Y. Yun, H. Yan, P. Chen, and Z. Shen. 2015. Osteoprotective effect of geraniin against ovariectomy-induced bone loss in rats. Bioorganic and Medicinal Chemistry Letters 25(3): 673–679.
16. Vassallo, A., M.C. Vaccaro, T.N. De, P.F. Dal, and A. Leone. 2013. Identification of the plant compound geraniin as a novel hsp90 inhibitor. Plos One 8(9): e74266.
17. Wu, N., Y. Zu, Y. Fu, Y. Kong, J. Zhao, X. Li, J. Li, M. Wink, and T. Efferth. 2010. Antioxidant activities and xanthine oxidase inhibitory effects of extracts and main polyphenolic compounds obtained from Geranium sibiricum L. Journal of Agricultural and Food Chemistry 58(8): 4737–4743.
18. Wang, P., X. Peng, Z.F. Wei, F.Y. Wei, W. Wang, W.D. Ma, L.P. Yao, Y.J. Fu, and Y.G. Zu. 2015. Geraniin exerts cytoprotective effect against cellular oxidative stress by upregulation of Nrf2-mediated antioxidant enzyme expression via PI3K/AKT and ERK1/2 pathway. Biochimica et Biophysica Acta 1850(9): 1751–1761.
19. Zhang, D., L. Chen, S. Li, Z. Gu, and J. Yan. 2008. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immunity 14(2): 99–107.
20. Zhang, F., J. Cui, X. Liu, L. Bo, X. Liu, Z. Xie, and Y. Bo. 2014. Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells. Stem Cell Research & Therapy 6(1): 1–13.
21. Lupino, E., C. Ramondetti, and M. Piccinini. 2012. IkappaB kinase beta is required for activation of NF-kappaB and AP-1 in CD3/CD28-stimulated primary CD4(+) T cells. Journal of Immunology 188(6): 2545–2555.
22. Grimm, M.J., V.R. Robert, N.G. Almyroudis, C.G. Dennis, A.N.H. Khan, A.C. D’Auria, K.L. Singel, B.A. Davidson, P.R. Knight, and T.S. Blackwell. 2013. Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. Journal of Immunology 190(8): 4175–4184.
23. Macmicking, J., Q.W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annual Review of Immunology 15(15): 323–350.
24. Zhang, X., M. Zhou, Y. Guo, Z. Song, and B. Liu. 2015. 1,25-dihydroxyvitamin D 3 promotes high glucose-induced M1 macrophage switching to M2 via the VDR-PPAR γ signaling pathway. Biomed Res Int 2015: 1–14.
25. Li, W., X. Wang, X. Niu, H. Zhang, Z. He, Y. Wang, W. Zhi, and F. Liu. 2016. Protective effects of nobiletin against endotoxic shock in mice through inhibiting TNF-alpha, IL-6, and HMGB1 and regulating NF-kappaB pathway. Inflammation.
26. Zhong, J., S. Fan, Z. Yan, S. Xiao, L. Wan, C. Chen, S. Zhong, L. Liu, and J. Liu. 2015. Effects of Nogo-A silencing on TNF-α and IL-6 secretion and TH downregulation in lipopolysaccharide-stimulated PC12 cells. Biomed Res Int 2015(13): 1–6.
27. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, D. Strand, J. Czaja, J.F. Schlaak, H.A. Lehr, F. Autschbach, G. Schurmann, N. Nishimoto, K. Yoshizaki, H. Ito, T. Kishimoto, P.R. Galle, S. Rose-John, and M.F. Neurath. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nature Medicine 6(5): 583–588.
28. Möller, B., and P.M. Villiger. 2006. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Springer Seminars in Immunopathology 27(4): 391–408.
29. Koh, K.K., S.H. Han, and M.J. Quon. 2005. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. Journal of the American College of Cardiology 46(11): 1978–1985.
30. Pagano, S., N. Satta, D. Werling, V. Offord, P.D. Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard, and N. Vuilleumier. 2012. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine 272(4): 344–357.
31. Pan, M., S.S. Lin, C.T. Ho, J. Lin, and J. Lin. 2000. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochemical Pharmacology 59(4): 357–367.
32. Kolodziej, H., A. Burmeister, W. Trun, O.A. Radtke, A.F. Kiderlen, H. Ito, T. Hatano, T. Yoshida, and L.Y. Foo. 2005. Tannins and related compounds induce nitric oxide synthase and cytokines gene expressions in Leishmania major-infected macrophage-like RAW 264.7 cells. Bioorganic and Medicinal Chemistry 13(23): 6470–6476.
33. Korhonen, R., A. Lahti, H. Kankaanranta, and E. Moilanen. 2005. Nitric oxide production and signaling in inflammation. Current Drug Targets. Inflammation and Allergy 4(4): 471–479.
34. Nagai, H., H. Kumamoto, M. Fukuda, and T. Takahashi. 2003. Inducible nitric oxide synthase and apoptosis-related factors in the synovial tissues of temporomandibular joints with internal derangement and osteoarthritis. Journal of Oral & Maxillofacial Surgery Official Journal of the American Association of Oral & Maxillofacial Surgeons 61(7): 801–807.
35. Tinker, A.C., and A.V. Wallace. 2006. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases? Current Topics in Medicinal Chemistry 6(2): 77–92 (16).
36. Kumar, R.K., S. Basu, H.D. Lemke, J. Jankowski, K. Kratz, A. Lendlein, and S.D. Tetali. 2015. Effect of extracts of poly(ether imide) microparticles on cytotoxicity, ROS generation and proinflammatory effects on human monocytic (THP-1) cells. Clinical Hemorheology and Microcirculation 49(10): 697–698.
37. Kayagaki, N., M.T. Wong, I.B. Stowe, S.R. Ramani, L.C. Gonzalez, S. Akashi-Takamura, K. Miyake, J. Zhang, W.P. Lee, A. Muszynski, L.S. Forsberg, R.W. Carlson, and V.M. Dixit. 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341(6151): 1246–1249.
38. Mattioli, I., A. Sebald, C. Bucher, R.P. Charles, H. Nakano, T. Doi, M. Kracht, and M.L. Schmitz. 2004. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. Journal of Immunology 172(10): 6336–6344.
39. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, S. Akira, K. Yamanishi, I. Kawase, K. Nakanishi, and T. Kishimoto. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17(5): 677–687.
40. Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y.C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K.P. Lu. 2003. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Molecular Cell 12(6): 1413–1426.
41. Strebovsky, J., P. Walker, R. Lang, and A.H. Dalpke. 2011. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus. Faseb J 25(3): 863–874.
42. Morgana Rodrigues, G.E., F.R.M. Leite, S. Luís Carlos, K. Keith Lough, and R. Carlos. 2013. Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK. Archives of Oral Biology 58(10): 1309–1317.